[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hormonal Infertility Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: H74D79416321EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Hormonal Infertility Treatment in Global, including the following market information:

Global Hormonal Infertility Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hormonal Infertility Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hormonal Infertility Treatment include Merck & Co. Inc, Par Pharmaceutical, TerSera Therapeutics LLC, Teva Pharmaceuticals, AbbVie Inc, Sanofi S.A, Incepta Pharmaceuticals Ltd and Serum Institute of India Pvt. Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormonal Infertility Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hormonal Infertility Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hormonal Infertility Treatment Market Segment Percentages, by Type, 2021 (%)
  • Medications
  • Surgery
  • Assisted Reproductive Technology
  • Others
Global Hormonal Infertility Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hormonal Infertility Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Specialty Clinics
  • Others
Global Hormonal Infertility Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hormonal Infertility Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hormonal Infertility Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hormonal Infertility Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Merck & Co. Inc
  • Par Pharmaceutical
  • TerSera Therapeutics LLC
  • Teva Pharmaceuticals
  • AbbVie Inc
  • Sanofi S.A
  • Incepta Pharmaceuticals Ltd
  • Serum Institute of India Pvt. Ltd
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hormonal Infertility Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hormonal Infertility Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HORMONAL INFERTILITY TREATMENT OVERALL MARKET SIZE

2.1 Global Hormonal Infertility Treatment Market Size: 2021 VS 2028
2.2 Global Hormonal Infertility Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hormonal Infertility Treatment Players in Global Market
3.2 Top Global Hormonal Infertility Treatment Companies Ranked by Revenue
3.3 Global Hormonal Infertility Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hormonal Infertility Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hormonal Infertility Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hormonal Infertility Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hormonal Infertility Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hormonal Infertility Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hormonal Infertility Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medications
  4.1.3 Surgery
  4.1.4 Assisted Reproductive Technology
  4.1.5 Others
4.2 By Type - Global Hormonal Infertility Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hormonal Infertility Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hormonal Infertility Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hormonal Infertility Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Hormonal Infertility Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hormonal Infertility Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hormonal Infertility Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hormonal Infertility Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hormonal Infertility Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hormonal Infertility Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hormonal Infertility Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hormonal Infertility Treatment Revenue, 2017-2028
  6.3.2 US Hormonal Infertility Treatment Market Size, 2017-2028
  6.3.3 Canada Hormonal Infertility Treatment Market Size, 2017-2028
  6.3.4 Mexico Hormonal Infertility Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hormonal Infertility Treatment Revenue, 2017-2028
  6.4.2 Germany Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.3 France Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.4 U.K. Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.5 Italy Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.6 Russia Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hormonal Infertility Treatment Market Size, 2017-2028
  6.4.8 Benelux Hormonal Infertility Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hormonal Infertility Treatment Revenue, 2017-2028
  6.5.2 China Hormonal Infertility Treatment Market Size, 2017-2028
  6.5.3 Japan Hormonal Infertility Treatment Market Size, 2017-2028
  6.5.4 South Korea Hormonal Infertility Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hormonal Infertility Treatment Market Size, 2017-2028
  6.5.6 India Hormonal Infertility Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hormonal Infertility Treatment Revenue, 2017-2028
  6.6.2 Brazil Hormonal Infertility Treatment Market Size, 2017-2028
  6.6.3 Argentina Hormonal Infertility Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hormonal Infertility Treatment Revenue, 2017-2028
  6.7.2 Turkey Hormonal Infertility Treatment Market Size, 2017-2028
  6.7.3 Israel Hormonal Infertility Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hormonal Infertility Treatment Market Size, 2017-2028
  6.7.5 UAE Hormonal Infertility Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck & Co. Inc
  7.1.1 Merck & Co. Inc Corporate Summary
  7.1.2 Merck & Co. Inc Business Overview
  7.1.3 Merck & Co. Inc Hormonal Infertility Treatment Major Product Offerings
  7.1.4 Merck & Co. Inc Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.1.5 Merck & Co. Inc Key News
7.2 Par Pharmaceutical
  7.2.1 Par Pharmaceutical Corporate Summary
  7.2.2 Par Pharmaceutical Business Overview
  7.2.3 Par Pharmaceutical Hormonal Infertility Treatment Major Product Offerings
  7.2.4 Par Pharmaceutical Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.2.5 Par Pharmaceutical Key News
7.3 TerSera Therapeutics LLC
  7.3.1 TerSera Therapeutics LLC Corporate Summary
  7.3.2 TerSera Therapeutics LLC Business Overview
  7.3.3 TerSera Therapeutics LLC Hormonal Infertility Treatment Major Product Offerings
  7.3.4 TerSera Therapeutics LLC Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.3.5 TerSera Therapeutics LLC Key News
7.4 Teva Pharmaceuticals
  7.4.1 Teva Pharmaceuticals Corporate Summary
  7.4.2 Teva Pharmaceuticals Business Overview
  7.4.3 Teva Pharmaceuticals Hormonal Infertility Treatment Major Product Offerings
  7.4.4 Teva Pharmaceuticals Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.4.5 Teva Pharmaceuticals Key News
7.5 AbbVie Inc
  7.5.1 AbbVie Inc Corporate Summary
  7.5.2 AbbVie Inc Business Overview
  7.5.3 AbbVie Inc Hormonal Infertility Treatment Major Product Offerings
  7.5.4 AbbVie Inc Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.5.5 AbbVie Inc Key News
7.6 Sanofi S.A
  7.6.1 Sanofi S.A Corporate Summary
  7.6.2 Sanofi S.A Business Overview
  7.6.3 Sanofi S.A Hormonal Infertility Treatment Major Product Offerings
  7.6.4 Sanofi S.A Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanofi S.A Key News
7.7 Incepta Pharmaceuticals Ltd
  7.7.1 Incepta Pharmaceuticals Ltd Corporate Summary
  7.7.2 Incepta Pharmaceuticals Ltd Business Overview
  7.7.3 Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Major Product Offerings
  7.7.4 Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.7.5 Incepta Pharmaceuticals Ltd Key News
7.8 Serum Institute of India Pvt. Ltd
  7.8.1 Serum Institute of India Pvt. Ltd Corporate Summary
  7.8.2 Serum Institute of India Pvt. Ltd Business Overview
  7.8.3 Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Major Product Offerings
  7.8.4 Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Revenue in Global Market (2017-2022)
  7.8.5 Serum Institute of India Pvt. Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Hormonal Infertility Treatment Market Opportunities & Trends in Global Market
Table 2. Hormonal Infertility Treatment Market Drivers in Global Market
Table 3. Hormonal Infertility Treatment Market Restraints in Global Market
Table 4. Key Players of Hormonal Infertility Treatment in Global Market
Table 5. Top Hormonal Infertility Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hormonal Infertility Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hormonal Infertility Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hormonal Infertility Treatment Product Type
Table 9. List of Global Tier 1 Hormonal Infertility Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hormonal Infertility Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hormonal Infertility Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hormonal Infertility Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hormonal Infertility Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hormonal Infertility Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hormonal Infertility Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hormonal Infertility Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hormonal Infertility Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hormonal Infertility Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hormonal Infertility Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hormonal Infertility Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hormonal Infertility Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hormonal Infertility Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hormonal Infertility Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hormonal Infertility Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Merck & Co. Inc Corporate Summary
Table 31. Merck & Co. Inc Hormonal Infertility Treatment Product Offerings
Table 32. Merck & Co. Inc Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Par Pharmaceutical Corporate Summary
Table 34. Par Pharmaceutical Hormonal Infertility Treatment Product Offerings
Table 35. Par Pharmaceutical Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 36. TerSera Therapeutics LLC Corporate Summary
Table 37. TerSera Therapeutics LLC Hormonal Infertility Treatment Product Offerings
Table 38. TerSera Therapeutics LLC Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceuticals Corporate Summary
Table 40. Teva Pharmaceuticals Hormonal Infertility Treatment Product Offerings
Table 41. Teva Pharmaceuticals Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AbbVie Inc Corporate Summary
Table 43. AbbVie Inc Hormonal Infertility Treatment Product Offerings
Table 44. AbbVie Inc Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi S.A Corporate Summary
Table 46. Sanofi S.A Hormonal Infertility Treatment Product Offerings
Table 47. Sanofi S.A Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Incepta Pharmaceuticals Ltd Corporate Summary
Table 49. Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Product Offerings
Table 50. Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Serum Institute of India Pvt. Ltd Corporate Summary
Table 52. Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Product Offerings
Table 53. Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Hormonal Infertility Treatment Segment by Type in 2021
Figure 2. Hormonal Infertility Treatment Segment by Application in 2021
Figure 3. Global Hormonal Infertility Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hormonal Infertility Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hormonal Infertility Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hormonal Infertility Treatment Revenue in 2021
Figure 8. By Type - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 12. US Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 24. China Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hormonal Infertility Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hormonal Infertility Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Merck & Co. Inc Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Par Pharmaceutical Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. TerSera Therapeutics LLC Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceuticals Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AbbVie Inc Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi S.A Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications